Track: Neuro-Oncology

The "Neuro-Oncology" track provides an in-depth
exploration of the diagnosis, treatment, and management of tumors affecting the
central and peripheral nervous systems. This session highlights cutting-edge
research, innovative therapies, and interdisciplinary approaches that are
transforming the landscape of neuro-oncology. Participants will engage with
experts to discuss advancements in diagnostics, targeted therapies, and
supportive care that improve patient outcomes and quality of life.
Primary Brain Tumors:
This session covers the classification, diagnosis, and treatment of primary
brain tumors, including gliomas, meningiomas, medulloblastomas, and
ependymomas. Discussions will focus on advancements in molecular profiling,
personalized treatment approaches, and the integration of surgery, radiation,
and chemotherapy in management plans.
Paediatric Neuro-Oncology:
This topic emphasizes the unique aspects of brain and spinal tumors in
children, such as medulloblastomas, pilocytic astrocytomas, and diffuse
intrinsic pontine gliomas (DIPG). Discussions will include genetic and
epigenetic factors, proton beam therapy, and supportive care strategies to
optimize developmental outcomes.
Glioblastoma: Challenges and Breakthroughs:
This segment focuses on glioblastoma, one of the most aggressive brain tumors,
highlighting recent progress in immunotherapy, tumor-treating fields (TTF), and
novel agents targeting the tumor microenvironment. Participants will explore
ongoing clinical trials and emerging molecular targets.
Advances in Surgical Neuro-Oncology:
This session explores technological innovations in neurosurgery, such as
fluorescence-guided surgery, intraoperative MRI, and robotic-assisted
techniques. The discussion will center on maximizing tumor resection while
preserving neurological function.
Radiation and Chemotherapy Innovations:
Participants will learn about the latest advances in radiation therapy
techniques, including stereotactic radiosurgery and proton therapy, as well as
the development of chemotherapeutic agents that cross the blood-brain barrier.
Strategies for minimizing side effects and enhancing efficacy will also be
discussed.
Immunotherapy in Neuro-Oncology:
This topic examines the role of immunotherapy, including immune checkpoint
inhibitors, CAR T-cell therapy, and cancer vaccines, in treating brain and
spinal tumors. Discussions will focus on the challenges of overcoming the
immunosuppressive tumor microenvironment and the potential for combination
therapies.
Tumor Biomarkers and Molecular Diagnostics:
This session highlights the importance of molecular biomarkers in tumor
classification, prognosis, and therapy selection. Topics include liquid biopsy
advancements, next-generation sequencing, and the integration of biomarkers
into clinical practice.
This track provides a comprehensive understanding of
neuro-oncology, offering actionable knowledge to enhance clinical practice,
foster research collaborations, and improve the overall care and outcomes for
patients with neurological tumors.
Scientific Highlights
- Advances in Neuropsychiatry
- Cognitive and Behavioural Neuroscience
- Mental Health and Psychiatry
- Neurological Disorders
- Child and Adolescent Psychiatry
- Neuro-Oncology
- Paediatric Neurology
- Central Nervous System and Neuropathology
- Neuroimaging and Brain Mapping
- Adult Neurogenesis
- Neuro-Ophthalmology & Visual Neuroscience
- Neurosurgery
- Neuropharmacology and Neuroendocrinology
- Neurotechnology and Neurorehabilitation
- Neuro Anatomy